MeSH Review:
Transplantation, Heterologous
- Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Goldman, M.J., Yang, Y., Wilson, J.M. Nat. Genet. (1995)
- Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model. Husain, S.R., Kreitman, R.J., Pastan, I., Puri, R.K. Nat. Med. (1999)
- DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. Giovanella, B.C., Stehlin, J.S., Wall, M.E., Wani, M.C., Nicholas, A.W., Liu, L.F., Silber, R., Potmesil, M. Science (1989)
- Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts. Couillard, S., Labrie, C., Bélanger, A., Candas, B., Pouliot, F., Labrie, F. J. Natl. Cancer Inst. (1998)
- PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., Kuliopulos, A. Cell (2005)
- Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Goldman, M.J., Anderson, G.M., Stolzenberg, E.D., Kari, U.P., Zasloff, M., Wilson, J.M. Cell (1997)
- Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Mizukami, Y., Jo, W.S., Duerr, E.M., Gala, M., Li, J., Zhang, X., Zimmer, M.A., Iliopoulos, O., Zukerberg, L.R., Kohgo, Y., Lynch, M.P., Rueda, B.R., Chung, D.C. Nat. Med. (2005)
- Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Yamada, K., Yazawa, K., Shimizu, A., Iwanaga, T., Hisashi, Y., Nuhn, M., O'Malley, P., Nobori, S., Vagefi, P.A., Patience, C., Fishman, J., Cooper, D.K., Hawley, R.J., Greenstein, J., Schuurman, H.J., Awwad, M., Sykes, M., Sachs, D.H. Nat. Med. (2005)
- Pharmacokinetics and mechanism of action of a doxorubicin-monoclonal antibody 9.2.27 conjugate directed to a human melanoma proteoglycan. Yang, H.M., Reisfeld, R.A. J. Natl. Cancer Inst. (1988)
- Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. Holland, P.A., Knox, W.F., Potten, C.S., Howell, A., Anderson, E., Baildam, A.D., Bundred, N.J. J. Natl. Cancer Inst. (1997)
- Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies. Watanabe, T., Naito, M., Kokubu, N., Tsuruo, T. J. Natl. Cancer Inst. (1997)
- Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. Nishimura, K., Nonomura, N., Satoh, E., Harada, Y., Nakayama, M., Tokizane, T., Fukui, T., Ono, Y., Inoue, H., Shin, M., Tsujimoto, Y., Takayama, H., Aozasa, K., Okuyama, A. J. Natl. Cancer Inst. (2001)
- Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity. Merchant, M.S., Woo, C.W., Mackall, C.L., Thiele, C.J. J. Natl. Cancer Inst. (2002)
- Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. Gautschi, O., Tschopp, S., Olie, R.A., Leech, S.H., Simões-Wüst, A.P., Ziegler, A., Baumann, B., Odermatt, B., Hall, J., Stahel, R.A., Zangemeister-Wittke, U. J. Natl. Cancer Inst. (2001)
- Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody. Pearson, J.W., Fogler, W.E., Volker, K., Usui, N., Goldenberg, S.K., Gruys, E., Riggs, C.W., Komschlies, K., Wiltrout, R.H., Tsuruo, T. J. Natl. Cancer Inst. (1991)
- The effects of adrenomedullin overexpression in breast tumor cells. Martínez, A., Vos, M., Guédez, L., Kaur, G., Chen, Z., Garayoa, M., Pío, R., Moody, T., Stetler-Stevenson, W.G., Kleinman, H.K., Cuttitta, F. J. Natl. Cancer Inst. (2002)
- Delayed xenograft rejection. Bach, F.H., Winkler, H., Ferran, C., Hancock, W.W., Robson, S.C. Immunol. Today (1996)
- Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo. Arcamone, F., Animati, F., Berettoni, M., Bigioni, M., Capranico, G., Casazza, A.M., Caserini, C., Cipollone, A., De Cesare, M., Franciotti, M., Lombardi, P., Madami, A., Manzini, S., Monteagudo, E., Polizzi, D., Pratesi, G., Righetti, S.C., Salvatore, C., Supino, R., Zunino, F. J. Natl. Cancer Inst. (1997)
- Recapitulation of normal and abnormal BB rat immune system development in scid mouse/rat lymphohemopoietic chimeras. Greiner, D.L., Shultz, L.D., Rossini, A.A., Mordes, J.P., Handler, E.S., Rajan, T.V. J. Clin. Invest. (1991)
- Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. Bonfil, R.D., Reddel, R.R., Ura, H., Reich, R., Fridman, R., Harris, C.C., Klein-Szanto, J.P. J. Natl. Cancer Inst. (1989)
- Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. Bals, R., Weiner, D.J., Meegalla, R.L., Wilson, J.M. J. Clin. Invest. (1999)
- Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft. Tan, M.H., Shimano, T., Chu, T.M. J. Natl. Cancer Inst. (1981)
- ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Heise, C., Sampson-Johannes, A., Williams, A., McCormick, F., Von Hoff, D.D., Kirn, D.H. Nat. Med. (1997)
- Imaging 26S proteasome activity and inhibition in living mice. Luker, G.D., Pica, C.M., Song, J., Luker, K.E., Piwnica-Worms, D. Nat. Med. (2003)
- Cytotoxicity of cisplatin and cisdiammine-1,1-cyclobutane dicarboxylate in MGH-U1 cells grown as monolayers, spheroids, and xenografts. Erlichman, C., Vidgen, D., Wu, A. J. Natl. Cancer Inst. (1985)
- Enhanced success rate of transplantation with human tumors in cyclophosphamide-treated nude mice. Braakhuis, B.J., Nauta, M.M., Romijn, J.C., Rutgers, D.H., Smink, T. J. Natl. Cancer Inst. (1986)
- Evaluation of cyclosporine-treated mice as hosts for growing and testing the chemosensitivity of first-transplant-generation human tumor xenografts implanted under the kidney capsule. Bennett, J.A., Pilon, V.A., Briggs, D.R., McKneally, M.F. J. Natl. Cancer Inst. (1985)
- Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Lyden, D., Young, A.Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B.L., Hynes, R.O., Zhuang, Y., Manova, K., Benezra, R. Nature (1999)
- Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Ravi, R., Mookerjee, B., Bhujwalla, Z.M., Sutter, C.H., Artemov, D., Zeng, Q., Dillehay, L.E., Madan, A., Semenza, G.L., Bedi, A. Genes Dev. (2000)
- CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. Mañes, S., Mira, E., Colomer, R., Montero, S., Real, L.M., Gómez-Moutón, C., Jiménez-Baranda, S., Garzón, A., Lacalle, R.A., Harshman, K., Ruíz, A., Martínez-A, C. J. Exp. Med. (2003)
- Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. Warren, R.S., Yuan, H., Matli, M.R., Gillett, N.A., Ferrara, N. J. Clin. Invest. (1995)
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. Kurihara, T., Brough, D.E., Kovesdi, I., Kufe, D.W. J. Clin. Invest. (2000)
- Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Ildstad, S.T., Sachs, D.H. Nature (1984)
- Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. Gross, J.L., Herblin, W.F., Dusak, B.A., Czerniak, P., Diamond, M.D., Sun, T., Eidsvoog, K., Dexter, D.L., Yayon, A. J. Natl. Cancer Inst. (1993)
- Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments. Buchegger, F., Pfister, C., Fournier, K., Prevel, F., Schreyer, M., Carrel, S., Mach, J.P. J. Clin. Invest. (1989)
- Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. Murphy, W.J., Back, T.C., Conlon, K.C., Komschlies, K.L., Ortaldo, J.R., Sayers, T.J., Wiltrout, R.H., Longo, D.L. J. Clin. Invest. (1993)
- Transplantation of discordant xenografts: a review of progress. Platt, J.L., Vercellotti, G.M., Dalmasso, A.P., Matas, A.J., Bolman, R.M., Najarian, J.S., Bach, F.H. Immunol. Today (1990)